{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:06:34Z","timestamp":1791317194110,"version":"4.3.1"},"reference-count":145,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2015,9,15]],"date-time":"2015-09-15T00:00:00Z","timestamp":1442275200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1007\/s12035-015-9430-9","type":"journal-article","created":{"date-parts":[[2015,9,15]],"date-time":"2015-09-15T03:25:55Z","timestamp":1442287555000},"page":"4981-4991","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Dissecting the Role of Anti-ganglioside Antibodies in Guillain-Barr\u00e9 Syndrome: an Animal Model Approach"],"prefix":"10.1007","volume":"53","author":[{"given":"Pallavi","family":"Asthana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquim Si Long","family":"Vong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gajendra","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond Chuen-Chung","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazim A.","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Him Eddie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,15]]},"reference":[{"issue":"2","key":"9430_CR1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/jns5.12020","volume":"18","author":"S Rinaldi","year":"2013","unstructured":"Rinaldi S (2013) Update on Guillain-Barre syndrome. J Peripher Nerv Syst 18(2):99\u2013112","journal-title":"J Peripher Nerv Syst"},{"issue":"2","key":"9430_CR2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000324710","volume":"36","author":"JJ Sejvar","year":"2011","unstructured":"Sejvar JJ et al (2011) Population incidence of Guillain-Barre syndrome: a systematic review and meta-analysis. Neuroepidemiology 36(2):123\u2013133","journal-title":"Neuroepidemiology"},{"issue":"6","key":"9430_CR3","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3329\/jhpn.v28i6.6602","volume":"28","author":"KO Poropatich","year":"2010","unstructured":"Poropatich KO, Walker CL, Black RE (2010) Quantifying the association between campylobacter infection and Guillain-Barre syndrome: a systematic review. J Health Popul Nutr 28(6):545\u2013552","journal-title":"J Health Popul Nutr"},{"key":"9430_CR4","doi-asserted-by":"crossref","first-page":"145S","DOI":"10.1046\/j.1365-2672.2001.01363.x","volume":"30","author":"RD Hadden","year":"2001","unstructured":"Hadden RD, Gregson NA (2001) Guillain-Barre syndrome and Campylobacter jejuni infection. Symp Ser Soc Appl Microbiol 30:145S\u2013154S","journal-title":"Symp Ser Soc Appl Microbiol"},{"issue":"4","key":"9430_CR5","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1212\/WNL.51.4.1110","volume":"51","author":"BC Jacobs","year":"1998","unstructured":"Jacobs BC et al (1998) The spectrum of antecedent infections in Guillain-Barre syndrome: a case\u2013control study. Neurology 51(4):1110\u20131115","journal-title":"Neurology"},{"issue":"7","key":"9430_CR6","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/cid\/cir074","volume":"52","author":"D Orlikowski","year":"2011","unstructured":"Orlikowski D et al (2011) Guillain-Barre syndrome following primary cytomegalovirus infection: a prospective cohort study. Clin Infect Dis 52(7):837\u2013844","journal-title":"Clin Infect Dis"},{"issue":"4","key":"9430_CR7","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1371\/journal.pone.0000344","volume":"2","author":"CC Tam","year":"2007","unstructured":"Tam CC et al (2007) Guillain-Barre syndrome and preceding infection with campylobacter, influenza and Epstein-Barr virus in the general practice research database. PLoS One 2(4):e344","journal-title":"PLoS One"},{"issue":"24","key":"9430_CR8","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMra1114525","volume":"366","author":"N Yuki","year":"2012","unstructured":"Yuki N, Hartung HP (2012) Guillain-Barre syndrome. N Engl J Med 366(24):2294\u20132304","journal-title":"N Engl J Med"},{"key":"9430_CR9","doi-asserted-by":"crossref","first-page":"d3908","DOI":"10.1136\/bmj.d3908","volume":"343","author":"J Dieleman","year":"2011","unstructured":"Dieleman J et al (2011) Guillain-Barre syndrome and adjuvanted pandemic influenza a (H1N1) 2009 vaccine: multinational case\u2013control study in Europe. BMJ 343:d3908","journal-title":"BMJ"},{"issue":"9","key":"9430_CR10","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S1473-3099(10)70140-7","volume":"10","author":"HC Lehmann","year":"2010","unstructured":"Lehmann HC et al (2010) Guillain-Barre syndrome after exposure to influenza virus. Lancet Infect Dis 10(9):643\u2013651","journal-title":"Lancet Infect Dis"},{"issue":"9876","key":"9430_CR11","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/S0140-6736(12)62189-8","volume":"381","author":"DA Salmon","year":"2013","unstructured":"Salmon DA et al (2013) Association between Guillain-Barre syndrome and influenza a (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis. Lancet 381(9876):1461\u20131468","journal-title":"Lancet"},{"issue":"7","key":"9430_CR12","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/glycob\/cwp027","volume":"19","author":"K Kaida","year":"2009","unstructured":"Kaida K, Ariga T, Yu RK (2009) Antiganglioside antibodies and their pathophysiological effects on Guillain-Barre syndrome and related disorders\u2014a review. Glycobiology 19(7):676\u2013692","journal-title":"Glycobiology"},{"issue":"5","key":"9430_CR13","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/ana.410390512","volume":"39","author":"CE Hafer-Macko","year":"1996","unstructured":"Hafer-Macko CE et al (1996) Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann Neurol 39(5):625\u2013635","journal-title":"Ann Neurol"},{"issue":"8","key":"9430_CR14","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","volume":"10","author":"B Berg van den","year":"2014","unstructured":"van den Berg B et al (2014) Guillain-Barre syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol 10(8):469\u2013482","journal-title":"Nat Rev Neurol"},{"issue":"16","key":"9430_CR15","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1212\/WNL.0b013e3181f88345","volume":"75","author":"L Ruts","year":"2010","unstructured":"Ruts L et al (2010) Pain in Guillain-Barre syndrome: a long-term follow-up study. Neurology 75(16):1439\u20131447","journal-title":"Neurology"},{"issue":"10","key":"9430_CR16","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(08)70215-1","volume":"7","author":"PA Doorn van","year":"2008","unstructured":"van Doorn PA, Ruts L, Jacobs BC (2008) Clinical features, pathogenesis, and treatment of Guillain-Barre syndrome. Lancet Neurol 7(10):939\u2013950","journal-title":"Lancet Neurol"},{"issue":"Pt 1","key":"9430_CR17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/brain\/awt285","volume":"137","author":"C Fokke","year":"2014","unstructured":"Fokke C et al (2014) Diagnosis of Guillain-Barre syndrome and validation of Brighton criteria. Brain 137(Pt 1):33\u201343","journal-title":"Brain"},{"issue":"9","key":"9430_CR18","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrneurol.2014.138","volume":"10","author":"BR Wakerley","year":"2014","unstructured":"Wakerley BR et al (2014) Guillain-Barre and Miller Fisher syndromes\u2014new diagnostic classification. Nat Rev Neurol 10(9):537\u2013544","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"9430_CR19","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/0005-2760(73)90055-6","volume":"296","author":"G Tettamanti","year":"1973","unstructured":"Tettamanti G et al (1973) A new procedure for the extraction, purification and fractionation of brain gangliosides. Biochim Biophys Acta 296(1):160\u2013170","journal-title":"Biochim Biophys Acta"},{"issue":"1\u20132","key":"9430_CR20","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jneuroim.2010.09.017","volume":"231","author":"JB Winer","year":"2011","unstructured":"Winer JB (2011) Guillain-Barre syndrome: clinical variants and their pathogenesis. J Neuroimmunol 231(1\u20132):70\u201372","journal-title":"J Neuroimmunol"},{"issue":"10","key":"9430_CR21","doi-asserted-by":"crossref","first-page":"537","DOI":"10.5650\/jos.60.537","volume":"60","author":"RK Yu","year":"2011","unstructured":"Yu RK et al (2011) Structures, biosynthesis, and functions of gangliosides\u2014an overview. J Oleo Sci 60(10):537\u2013544","journal-title":"J Oleo Sci"},{"issue":"9","key":"9430_CR22","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.febslet.2009.10.011","volume":"584","author":"RL Schnaar","year":"2010","unstructured":"Schnaar RL (2010) Brain gangliosides in axon-myelin stability and axon regeneration. FEBS Lett 584(9):1741\u20131747","journal-title":"FEBS Lett"},{"issue":"10","key":"9430_CR23","doi-asserted-by":"crossref","first-page":"xi","DOI":"10.1093\/oxfordjournals.glycob.a018822","volume":"8","author":"S Hakomori","year":"1998","unstructured":"Hakomori S et al (1998) New insights in glycosphingolipid function: \u201cglycosignaling domain,\u201d a cell surface assembly of glycosphingolipids with signal transducer molecules, involved in cell adhesion coupled with signaling. Glycobiology 8(10):xi\u2013xix","journal-title":"Glycobiology"},{"issue":"Pt 3","key":"9430_CR24","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/brain\/122.3.449","volume":"122","author":"KA Sheikh","year":"1999","unstructured":"Sheikh KA et al (1999) The distribution of ganglioside-like moieties in peripheral nerves. Brain 122(Pt 3):449\u2013460","journal-title":"Brain"},{"issue":"5","key":"9430_CR25","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1161\/hy1101.093104","volume":"38","author":"I Gouni-Berthold","year":"2001","unstructured":"Gouni-Berthold I et al (2001) Gangliosides GM1 and GM2 induce vascular smooth muscle cell proliferation via extracellular signal-regulated kinase 1\/2 pathway. Hypertension 38(5):1030\u20131037","journal-title":"Hypertension"},{"issue":"3","key":"9430_CR26","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1006\/bbrc.1994.1356","volume":"199","author":"J Kopitz","year":"1994","unstructured":"Kopitz J et al (1994) Role of plasma membrane ganglioside sialidase of human neuroblastoma cells in growth control and differentiation. Biochem Biophys Res Commun 199(3):1188\u20131193","journal-title":"Biochem Biophys Res Commun"},{"issue":"13","key":"9430_CR27","doi-asserted-by":"crossref","first-page":"7532","DOI":"10.1073\/pnas.96.13.7532","volume":"96","author":"KA Sheikh","year":"1999","unstructured":"Sheikh KA et al (1999) Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects. Proc Natl Acad Sci U S A 96(13):7532\u20137537","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"9430_CR28","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.neuroscience.2005.07.035","volume":"135","author":"Y Sugiura","year":"2005","unstructured":"Sugiura Y et al (2005) Sensory nerve-dominant nerve degeneration and remodeling in the mutant mice lacking complex gangliosides. Neuroscience 135(4):1167\u20131178","journal-title":"Neuroscience"},{"issue":"20","key":"9430_CR29","doi-asserted-by":"crossref","first-page":"10662","DOI":"10.1073\/pnas.93.20.10662","volume":"93","author":"K Takamiya","year":"1996","unstructured":"Takamiya K et al (1996) Mice with disrupted GM2\/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system. Proc Natl Acad Sci U S A 93(20):10662\u201310667","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"9430_CR30","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1073\/pnas.93.2.814","volume":"93","author":"LJ Yang","year":"1996","unstructured":"Yang LJ et al (1996) Gangliosides are neuronal ligands for myelin-associated glycoprotein. Proc Natl Acad Sci U S A 93(2):814\u2013818","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"23","key":"9430_CR31","doi-asserted-by":"crossref","first-page":"20280","DOI":"10.1074\/jbc.M100345200","volume":"276","author":"M Vinson","year":"2001","unstructured":"Vinson M et al (2001) Myelin-associated glycoprotein interacts with ganglioside GT1b. A mechanism for neurite outgrowth inhibition. J Biol Chem 276(23):20280\u201320285","journal-title":"J Biol Chem"},{"issue":"12","key":"9430_CR32","doi-asserted-by":"crossref","first-page":"8412","DOI":"10.1073\/pnas.072211699","volume":"99","author":"AA Vyas","year":"2002","unstructured":"Vyas AA et al (2002) Gangliosides are functional nerve cell ligands for myelin-associated glycoprotein (MAG), an inhibitor of nerve regeneration. Proc Natl Acad Sci U S A 99(12):8412\u20138417","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"9430_CR33","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1194\/jlr.R800009-JLR200","volume":"49","author":"RW Ledeen","year":"2008","unstructured":"Ledeen RW, Wu G (2008) Nuclear sphingolipids: metabolism and signaling. J Lipid Res 49(6):1176\u20131186","journal-title":"J Lipid Res"},{"issue":"2","key":"9430_CR34","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1006\/exnr.2000.7504","volume":"166","author":"S Chiavegatto","year":"2000","unstructured":"Chiavegatto S et al (2000) A functional role for complex gangliosides: motor deficits in GM2\/GD2 synthase knockout mice. Exp Neurol 166(2):227\u2013234","journal-title":"Exp Neurol"},{"issue":"3","key":"9430_CR35","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1074\/jbc.C100395200","volume":"277","author":"M Okada","year":"2002","unstructured":"Okada M et al (2002) b-series ganglioside deficiency exhibits no definite changes in the neurogenesis and the sensitivity to Fas-mediated apoptosis but impairs regeneration of the lesioned hypoglossal nerve. J Biol Chem 277(3):1633\u20131636","journal-title":"J Biol Chem"},{"issue":"1","key":"9430_CR36","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.bbr.2008.10.024","volume":"198","author":"O Tajima","year":"2009","unstructured":"Tajima O et al (2009) Reduced motor and sensory functions and emotional response in GM3-only mice: emergence from early stage of life and exacerbation with aging. Behav Brain Res 198(1):74\u201382","journal-title":"Behav Brain Res"},{"issue":"1","key":"9430_CR37","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bbr.2009.09.005","volume":"206","author":"O Tajima","year":"2010","unstructured":"Tajima O et al (2010) Dysfunction of muscarinic acetylcholine receptors as a substantial basis for progressive neurological deterioration in GM3-only mice. Behav Brain Res 206(1):101\u2013108","journal-title":"Behav Brain Res"},{"issue":"8","key":"9430_CR38","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1073\/pnas.0407785102","volume":"102","author":"T Yamashita","year":"2005","unstructured":"Yamashita T et al (2005) Interruption of ganglioside synthesis produces central nervous system degeneration and altered axon-glial interactions. Proc Natl Acad Sci U S A 102(8):2725\u20132730","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9430_CR39","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/978-1-59745-066-9_11","volume":"444","author":"E Guetta","year":"2008","unstructured":"Guetta E, Peleg L (2008) Rapid detection of fetal Mendelian disorders: Tay-Sachs disease. Methods Mol Biol 444:147\u2013159","journal-title":"Methods Mol Biol"},{"issue":"25","key":"9430_CR40","doi-asserted-by":"crossref","first-page":"10195","DOI":"10.1523\/JNEUROSCI.0822-13.2013","volume":"33","author":"K Sandhoff","year":"2013","unstructured":"Sandhoff K, Harzer K (2013) Gangliosides and gangliosidoses: principles of molecular and metabolic pathogenesis. J Neurosci 33(25):10195\u201310208","journal-title":"J Neurosci"},{"issue":"Pt 12","key":"9430_CR41","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/brain\/awt270","volume":"136","author":"GV Harlalka","year":"2013","unstructured":"Harlalka GV et al (2013) Mutations in B4GALNT1 (GM2 synthase) underlie a new disorder of ganglioside biosynthesis. Brain 136(Pt 12):3618\u20133624","journal-title":"Brain"},{"issue":"11","key":"9430_CR42","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/ng1460","volume":"36","author":"MA Simpson","year":"2004","unstructured":"Simpson MA et al (2004) Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase. Nat Genet 36(11):1225\u20131229","journal-title":"Nat Genet"},{"issue":"9","key":"9430_CR43","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/j.febslet.2009.10.012","volume":"584","author":"J Inokuchi","year":"2010","unstructured":"Inokuchi J (2010) Membrane microdomains and insulin resistance. FEBS Lett 584(9):1864\u20131871","journal-title":"FEBS Lett"},{"issue":"23","key":"9430_CR44","doi-asserted-by":"crossref","first-page":"9483","DOI":"10.1073\/pnas.0903279106","volume":"106","author":"M Yoshikawa","year":"2009","unstructured":"Yoshikawa M et al (2009) Mice lacking ganglioside GM3 synthase exhibit complete hearing loss due to selective degeneration of the organ of corti. Proc Natl Acad Sci U S A 106(23):9483\u20139488","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"9430_CR45","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a112795","volume":"110","author":"LB Schonberger","year":"1979","unstructured":"Schonberger LB et al (1979) Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976\u20131977. Am J Epidemiol 110(2):105\u2013123","journal-title":"Am J Epidemiol"},{"issue":"19\u201320","key":"9430_CR46","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1007\/s00018-005-5188-y","volume":"62","author":"I Mocchetti","year":"2005","unstructured":"Mocchetti I (2005) Exogenous gangliosides, neuronal plasticity and repair, and the neurotrophins. Cell Mol Life Sci 62(19\u201320):2283\u20132294","journal-title":"Cell Mol Life Sci"},{"issue":"39","key":"9430_CR47","doi-asserted-by":"crossref","first-page":"26569","DOI":"10.1074\/jbc.M109.027391","volume":"284","author":"C Chen","year":"2009","unstructured":"Chen C et al (2009) Gangliosides as high affinity receptors for tetanus neurotoxin. J Biol Chem 284(39):26569\u201326577","journal-title":"J Biol Chem"},{"key":"9430_CR48","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1099\/00221287-24-1-107","volume":"24","author":"WE Heyningen Van","year":"1961","unstructured":"Van Heyningen WE, Miller PA (1961) The fixation of tetanus toxin by ganglioside. J Gen Microbiol 24:107\u2013119","journal-title":"J Gen Microbiol"},{"issue":"48","key":"9430_CR49","doi-asserted-by":"crossref","first-page":"40806","DOI":"10.1074\/jbc.M112.404244","volume":"287","author":"AP Karalewitz","year":"2012","unstructured":"Karalewitz AP et al (2012) Botulinum neurotoxin serotype C associates with dual ganglioside receptors to facilitate cell entry. J Biol Chem 287(48):40806\u201340816","journal-title":"J Biol Chem"},{"issue":"2","key":"9430_CR50","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1006\/mpat.1998.0214","volume":"25","author":"S Kozaki","year":"1998","unstructured":"Kozaki S et al (1998) Ganglioside GT1b as a complementary receptor component for Clostridium botulinum neurotoxins. Microb Pathog 25(2):91\u201399","journal-title":"Microb Pathog"},{"issue":"23","key":"9430_CR51","doi-asserted-by":"crossref","first-page":"4486","DOI":"10.1111\/j.1742-4658.2011.08166.x","volume":"278","author":"AR Kroken","year":"2011","unstructured":"Kroken AR et al (2011) Unique ganglioside binding by botulinum neurotoxins C and D-SA. FEBS J 278(23):4486\u20134496","journal-title":"FEBS J"},{"issue":"30","key":"9430_CR52","doi-asserted-by":"crossref","first-page":"26828","DOI":"10.1074\/jbc.M111.254086","volume":"286","author":"AR Kroken","year":"2011","unstructured":"Kroken AR et al (2011) Novel ganglioside-mediated entry of botulinum neurotoxin serotype D into neurons. J Biol Chem 286(30):26828\u201326837","journal-title":"J Biol Chem"},{"issue":"Pt 12","key":"9430_CR53","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1093\/brain\/awf272","volume":"125","author":"HJ Willison","year":"2002","unstructured":"Willison HJ, Yuki N (2002) Peripheral neuropathies and anti-glycolipid antibodies. Brain 125(Pt 12):2591\u20132625","journal-title":"Brain"},{"issue":"4","key":"9430_CR54","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/jcp.47.4.300","volume":"47","author":"AS Bansal","year":"1994","unstructured":"Bansal AS et al (1994) IgM ganglioside GM1 antibodies in patients with autoimmune disease or neuropathy, and controls. J Clin Pathol 47(4):300\u2013302","journal-title":"J Clin Pathol"},{"issue":"9497","key":"9430_CR55","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","volume":"366","author":"RA Hughes","year":"2005","unstructured":"Hughes RA, Cornblath DR (2005) Guillain-Barre syndrome. Lancet 366(9497):1653\u20131666","journal-title":"Lancet"},{"issue":"2","key":"9430_CR56","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1085-9489.2005.0010202.x","volume":"10","author":"HJ Willison","year":"2005","unstructured":"Willison HJ (2005) The immunobiology of Guillain-Barre syndromes. J Peripher Nerv Syst 10(2):94\u2013112","journal-title":"J Peripher Nerv Syst"},{"issue":"1\u20132","key":"9430_CR57","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0165-5728(99)00213-1","volume":"100","author":"HJ Willison","year":"1999","unstructured":"Willison HJ, O\u2019Hanlon GM (1999) The immunopathogenesis of Miller Fisher syndrome. J Neuroimmunol 100(1\u20132):3\u201312","journal-title":"J Neuroimmunol"},{"issue":"1","key":"9430_CR58","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1473-3099(01)00019-6","volume":"1","author":"N Yuki","year":"2001","unstructured":"Yuki N (2001) Infectious origins of, and molecular mimicry in, Guillain-Barre and Fisher syndromes. Lancet Infect Dis 1(1):29\u201337","journal-title":"Lancet Infect Dis"},{"issue":"Pt 5","key":"9430_CR59","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/brain\/124.5.893","volume":"124","author":"GM O\u2019Hanlon","year":"2001","unstructured":"O\u2019Hanlon GM et al (2001) Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal. Brain 124(Pt 5):893\u2013906","journal-title":"Brain"},{"issue":"2","key":"9430_CR60","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/jnnp.56.2.204","volume":"56","author":"HJ Willison","year":"1993","unstructured":"Willison HJ et al (1993) Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. J Neurol Neurosurg Psychiatry 56(2):204\u2013206","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"9430_CR61","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0022-510X(67)90058-5","volume":"4","author":"JF Cummings","year":"1966","unstructured":"Cummings JF, Haas DC (1966) Coonhound paralysis. An acute idiopathic polyradiculoneuritis in dogs resembling the Landry-Guillain-Barre syndrome. J Neurol Sci 4(1):51\u201381","journal-title":"J Neurol Sci"},{"issue":"1","key":"9430_CR62","first-page":"189","volume":"66","author":"JF Cummings","year":"1972","unstructured":"Cummings JF, Haas DC (1972) Animal model for human disease: idiopathic polyneuritis, Guillain-Barre syndrome. Animal model: Coonhound paralysis, idiopathic polyradiculoneuritis of coonhounds. Am J Pathol 66(1):189\u2013192","journal-title":"Am J Pathol"},{"issue":"5","key":"9430_CR63","first-page":"675","volume":"74","author":"RS Hawe","year":"1979","unstructured":"Hawe RS (1979) Acute idiopathic polyradiculoneuritis in a dog (a case report and discussion). Vet Med Small Anim Clin 74(5):675\u2013680","journal-title":"Vet Med Small Anim Clin"},{"issue":"1","key":"9430_CR64","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/jns5.12011","volume":"18","author":"A Rupp","year":"2013","unstructured":"Rupp A et al (2013) Anti-GM2 ganglioside antibodies are a biomarker for acute canine polyradiculoneuritis. J Peripher Nerv Syst 18(1):75\u201388","journal-title":"J Peripher Nerv Syst"},{"issue":"1","key":"9430_CR65","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/03079458208436090","volume":"11","author":"PM Biggs","year":"1982","unstructured":"Biggs PM et al (1982) Idiopathic polyneuritis in SPF chickens. Avian Pathol 11(1):163\u2013178","journal-title":"Avian Pathol"},{"issue":"3","key":"9430_CR66","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.2042-3306.1973.tb03206.x","volume":"5","author":"AG Greenwood","year":"1973","unstructured":"Greenwood AG, Barker J, McLeish I (1973) Neuritis of the cauda equina in a horse. Equine Vet J 5(3):111\u2013115","journal-title":"Equine Vet J"},{"issue":"10","key":"9430_CR67","first-page":"1162","volume":"68","author":"JP Manning","year":"1973","unstructured":"Manning JP, Gosser HS (1973) Neuritis of the cauda equina in horses. Vet Med Small Anim Clin 68(10):1162\u20131165","journal-title":"Vet Med Small Anim Clin"},{"issue":"2","key":"9430_CR68","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1084\/jem.102.2.213","volume":"102","author":"BH Waksman","year":"1955","unstructured":"Waksman BH, Adams RD (1955) Allergic neuritis: an experimental disease of rabbits induced by the injection of peripheral nervous tissue and adjuvants. J Exp Med 102(2):213\u2013236","journal-title":"J Exp Med"},{"issue":"8814","key":"9430_CR69","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0140-6736(92)92388-V","volume":"340","author":"SH Notermans","year":"1992","unstructured":"Notermans SH, Wokke JH, van den Berg LH (1992) Botulism and Guillain-Barre syndrome. Lancet 340(8814):303","journal-title":"Lancet"},{"issue":"1","key":"9430_CR70","first-page":"99","volume":"95","author":"K Saida","year":"1979","unstructured":"Saida K et al (1979) In vivo demyelination induced by intraneural injection of anti-galactocerebroside serum: a morphologic study. Am J Pathol 95(1):99\u2013116","journal-title":"Am J Pathol"},{"issue":"4","key":"9430_CR71","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00005072-197907000-00003","volume":"38","author":"ME Smith","year":"1979","unstructured":"Smith ME, Forno LS, Hofmann WW (1979) Experimental allergic neuritis in the Lewis rat. J Neuropathol Exp Neurol 38(4):377\u2013391","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"9430_CR72","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1574-695X.2007.00225.x","volume":"50","author":"VN Perera","year":"2007","unstructured":"Perera VN et al (2007) Molecular mimicry in Campylobacter jejuni: role of the lipo-oligosaccharide core oligosaccharide in inducing anti-ganglioside antibodies. FEMS Immunol Med Microbiol 50(1):27\u201336","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"2","key":"9430_CR73","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/mus.20457","volume":"33","author":"XM Shu","year":"2006","unstructured":"Shu XM, Cai FC, Zhang XP (2006) Carbohydrate mimicry of Campylobacter jejuni lipooligosaccharide is critical for the induction of anti-GM1 antibody and neuropathy. Muscle Nerve 33(2):225\u2013231","journal-title":"Muscle Nerve"},{"issue":"1","key":"9430_CR74","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0304-4165(92)90168-T","volume":"1117","author":"M Kotani","year":"1992","unstructured":"Kotani M et al (1992) Generation of one set of monoclonal antibodies specific for a-pathway ganglio-series gangliosides. Biochim Biophys Acta 1117(1):97\u2013103","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"9430_CR75","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0005-2760(92)90110-H","volume":"1123","author":"H Ozawa","year":"1992","unstructured":"Ozawa H et al (1992) Generation of one set of monoclonal antibodies specific for b-pathway ganglio-series gangliosides. Biochim Biophys Acta 1123(2):184\u2013190","journal-title":"Biochim Biophys Acta"},{"key":"9430_CR76","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/978-1-4684-7844-0_30","volume":"125","author":"MM Rapport","year":"1980","unstructured":"Rapport MM et al (1980) Antibodies to total brain gangliosides: titer and specificity of Antisera. Adv Exp Med Biol 125:327\u2013334","journal-title":"Adv Exp Med Biol"},{"issue":"15","key":"9430_CR77","doi-asserted-by":"crossref","first-page":"8397","DOI":"10.1074\/jbc.270.15.8397","volume":"270","author":"PJ Declerck","year":"1995","unstructured":"Declerck PJ et al (1995) Generation of monoclonal antibodies against autologous proteins in gene-inactivated mice. J Biol Chem 270(15):8397\u20138400","journal-title":"J Biol Chem"},{"issue":"1","key":"9430_CR78","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1046\/j.1471-4159.2000.0750404.x","volume":"75","author":"MP Lunn","year":"2000","unstructured":"Lunn MP et al (2000) High-affinity anti-ganglioside IgG antibodies raised in complex ganglioside knockout mice: reexamination of GD1a immunolocalization. J Neurochem 75(1):404\u2013412","journal-title":"J Neurochem"},{"issue":"3","key":"9430_CR79","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0092-8674(87)90646-5","volume":"51","author":"KR Thomas","year":"1987","unstructured":"Thomas KR, Capecchi MR (1987) Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 51(3):503\u2013512","journal-title":"Cell"},{"issue":"4","key":"9430_CR80","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1172\/JCI5542","volume":"103","author":"Y Liu","year":"1999","unstructured":"Liu Y et al (1999) A genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder. J Clin Invest 103(4):497\u2013505","journal-title":"J Clin Invest"},{"issue":"2","key":"9430_CR81","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1006\/abio.2001.5540","volume":"302","author":"RL Schnaar","year":"2002","unstructured":"Schnaar RL et al (2002) Immunoglobulin G-class mouse monoclonal antibodies to major brain gangliosides. Anal Biochem 302(2):276\u2013284","journal-title":"Anal Biochem"},{"issue":"Pt 1","key":"9430_CR82","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/brain\/123.1.116","volume":"123","author":"K Kaida","year":"2000","unstructured":"Kaida K et al (2000) Guillain-Barre syndrome with antibody to a ganglioside, N-acetylgalactosaminyl GD1a. Brain 123(Pt 1):116\u2013124","journal-title":"Brain"},{"issue":"4","key":"9430_CR83","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/ana.20222","volume":"56","author":"K Kaida","year":"2004","unstructured":"Kaida K et al (2004) Ganglioside complexes as new target antigens in Guillain-Barre syndrome. Ann Neurol 56(4):567\u2013571","journal-title":"Ann Neurol"},{"issue":"5","key":"9430_CR84","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/j.1471-4159.2010.07029.x","volume":"116","author":"S Kusunoki","year":"2011","unstructured":"Kusunoki S, Kaida K (2011) Antibodies against ganglioside complexes in Guillain-Barre syndrome and related disorders. J Neurochem 116(5):828\u2013832","journal-title":"J Neurochem"},{"issue":"1\u20132","key":"9430_CR85","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jneuroim.2006.09.013","volume":"182","author":"K Kaida","year":"2007","unstructured":"Kaida K et al (2007) Anti-ganglioside complex antibodies associated with severe disability in GBS. J Neuroimmunol 182(1\u20132):212\u2013218","journal-title":"J Neuroimmunol"},{"issue":"Pt 11","key":"9430_CR86","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1093\/brain\/awf258","volume":"125","author":"Y Gong","year":"2002","unstructured":"Gong Y et al (2002) Localization of major gangliosides in the PNS: implications for immune neuropathies. Brain 125(Pt 11):2491\u20132506","journal-title":"Brain"},{"issue":"7","key":"9430_CR87","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/(SICI)1097-4598(199707)20:7<840::AID-MUS8>3.0.CO;2-7","volume":"20","author":"S Kusunoki","year":"1997","unstructured":"Kusunoki S et al (1997) Binding of antibodies against GM1 and GD1b in human peripheral nerve. Muscle Nerve 20(7):840\u2013845","journal-title":"Muscle Nerve"},{"issue":"4","key":"9430_CR88","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ana.410390404","volume":"39","author":"S Kusunoki","year":"1996","unstructured":"Kusunoki S et al (1996) Experimental sensory neuropathy induced by sensitization with ganglioside GD1b. Ann Neurol 39(4):424\u2013431","journal-title":"Ann Neurol"},{"issue":"2","key":"9430_CR89","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/ana.20173","volume":"56","author":"KA Sheikh","year":"2004","unstructured":"Sheikh KA et al (2004) An anti-ganglioside antibody-secreting hybridoma induces neuropathy in mice. Ann Neurol 56(2):228\u2013239","journal-title":"Ann Neurol"},{"issue":"17","key":"9430_CR90","doi-asserted-by":"crossref","first-page":"6770","DOI":"10.1523\/JNEUROSCI.4926-14.2015","volume":"35","author":"L He","year":"2015","unstructured":"He L et al (2015) Anti-ganglioside antibodies induce nodal and axonal injury via Fcgamma receptor-mediated inflammation. J Neurosci 35(17):6770\u20136785","journal-title":"J Neurosci"},{"issue":"4","key":"9430_CR91","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/ana.410370409","volume":"37","author":"JD Pollard","year":"1995","unstructured":"Pollard JD et al (1995) Activated T cells of nonneural specificity open the blood-nerve barrier to circulating antibody. Ann Neurol 37(4):467\u2013475","journal-title":"Ann Neurol"},{"issue":"1\u20132","key":"9430_CR92","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0165-5728(94)00164-J","volume":"57","author":"JM Spies","year":"1995","unstructured":"Spies JM et al (1995) Synergy between antibody and P2-reactive T cells in experimental allergic neuritis. J Neuroimmunol 57(1\u20132):77\u201384","journal-title":"J Neuroimmunol"},{"issue":"Pt 4","key":"9430_CR93","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/brain\/118.4.857","volume":"118","author":"JM Spies","year":"1995","unstructured":"Spies JM et al (1995) Intraneural activated T cells cause focal breakdown of the blood-nerve barrier. Brain 118(Pt 4):857\u2013868","journal-title":"Brain"},{"issue":"Pt 7","key":"9430_CR94","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1093\/brain\/122.7.1283","volume":"122","author":"KW Westland","year":"1999","unstructured":"Westland KW et al (1999) Activated non-neural specific T cells open the blood\u2013brain barrier to circulating antibodies. Brain 122(Pt 7):1283\u20131291","journal-title":"Brain"},{"issue":"28","key":"9430_CR95","doi-asserted-by":"crossref","first-page":"9533","DOI":"10.1523\/JNEUROSCI.2281-10.2010","volume":"30","author":"PH Lopez","year":"2010","unstructured":"Lopez PH et al (2010) Passive transfer of IgG anti-GM1 antibodies impairs peripheral nerve repair. J Neurosci 30(28):9533\u20139541","journal-title":"J Neurosci"},{"issue":"6","key":"9430_CR96","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/ana.1012","volume":"49","author":"N Yuki","year":"2001","unstructured":"Yuki N et al (2001) Animal model of axonal Guillain-Barre syndrome induced by sensitization with GM1 ganglioside. Ann Neurol 49(6):712\u2013720","journal-title":"Ann Neurol"},{"issue":"24","key":"9430_CR97","doi-asserted-by":"crossref","first-page":"7636","DOI":"10.1073\/pnas.80.24.7636","volume":"80","author":"H Fukunaga","year":"1983","unstructured":"Fukunaga H et al (1983) Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones. Proc Natl Acad Sci U S A 80(24):7636\u20137640","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9430_CR98","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1113\/jphysiol.1983.sp014943","volume":"344","author":"B Lang","year":"1983","unstructured":"Lang B et al (1983) Antibodies to motor nerve terminals: an electrophysiological study of a human myasthenic syndrome transferred to mouse. J Physiol 344:335\u2013345","journal-title":"J Physiol"},{"issue":"3","key":"9430_CR99","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJM197701202960301","volume":"296","author":"KV Toyka","year":"1977","unstructured":"Toyka KV et al (1977) Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice. N Engl J Med 296(3):125\u2013131","journal-title":"N Engl J Med"},{"issue":"7","key":"9430_CR100","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/glia.20503","volume":"55","author":"K Susuki","year":"2007","unstructured":"Susuki K et al (2007) Gangliosides contribute to stability of paranodal junctions and ion channel clusters in myelinated nerve fibers. Glia 55(7):746\u2013757","journal-title":"Glia"},{"issue":"Pt 1","key":"9430_CR101","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/brain\/107.1.219","volume":"107","author":"WF Brown","year":"1984","unstructured":"Brown WF, Feasby TE (1984) Conduction block and denervation in Guillain-Barre polyneuropathy. Brain 107(Pt 1):219\u2013239","journal-title":"Brain"},{"issue":"2","key":"9430_CR102","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0022-510X(99)00173-2","volume":"168","author":"M Carpo","year":"1999","unstructured":"Carpo M et al (1999) Clinical presentation and outcome of Guillain-Barre and related syndromes in relation to anti-ganglioside antibodies. J Neurol Sci 168(2):78\u201384","journal-title":"J Neurol Sci"},{"issue":"1","key":"9430_CR103","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/mus.20240","volume":"31","author":"C Dornonville de la Cour","year":"2005","unstructured":"de la Cour Dornonville C et al (2005) Electrophysiological signs of permanent axonal loss in a follow-up study of patients with Guillain-Barre syndrome. Muscle Nerve 31(1):70\u201377","journal-title":"Muscle Nerve"},{"issue":"1\u20132","key":"9430_CR104","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0022-510X(01)00580-9","volume":"190","author":"R Press","year":"2001","unstructured":"Press R et al (2001) Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain-Barre syndrome. J Neurol Sci 190(1\u20132):41\u201347","journal-title":"J Neurol Sci"},{"issue":"6","key":"9430_CR105","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/mus.880160610","volume":"16","author":"N Yuki","year":"1993","unstructured":"Yuki N et al (1993) Association of IgG anti-GD1a antibody with severe Guillain-Barre syndrome. Muscle Nerve 16(6):642\u2013647","journal-title":"Muscle Nerve"},{"issue":"5","key":"9430_CR106","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1136\/jnnp.2004.051136","volume":"76","author":"A Hiraga","year":"2005","unstructured":"Hiraga A et al (2005) Recovery patterns and long term prognosis for axonal Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry 76(5):719\u2013722","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"9430_CR107","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/ana.410440210","volume":"44","author":"S Kuwabara","year":"1998","unstructured":"Kuwabara S et al (1998) IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barre syndrome. Ann Neurol 44(2):202\u2013208","journal-title":"Ann Neurol"},{"issue":"1","key":"9430_CR108","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1523\/JNEUROSCI.4017-06.2007","volume":"27","author":"HC Lehmann","year":"2007","unstructured":"Lehmann HC et al (2007) Passive immunization with anti-ganglioside antibodies directly inhibits axon regeneration in an animal model. J Neurosci 27(1):27\u201334","journal-title":"J Neurosci"},{"issue":"10","key":"9430_CR109","doi-asserted-by":"crossref","first-page":"6885","DOI":"10.1074\/jbc.C000847200","volume":"276","author":"H Kawai","year":"2001","unstructured":"Kawai H et al (2001) Mice expressing only monosialoganglioside GM3 exhibit lethal audiogenic seizures. J Biol Chem 276(10):6885\u20136888","journal-title":"J Biol Chem"},{"key":"9430_CR110","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1084\/jem.120.5.897","volume":"120","author":"B Cinader","year":"1964","unstructured":"Cinader B, Dubiski S, Wardlaw AC (1964) Distribution, inheritance, and properties of an antigen, Mub1, and its relation to hemolytic complement. J Exp Med 120:897\u2013924","journal-title":"J Exp Med"},{"issue":"5","key":"9430_CR111","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1523\/JNEUROSCI.3829-10.2011","volume":"31","author":"G Zhang","year":"2011","unstructured":"Zhang G et al (2011) Anti-ganglioside antibody-mediated activation of RhoA induces inhibition of neurite outgrowth. J Neurosci 31(5):1664\u20131675","journal-title":"J Neurosci"},{"issue":"4","key":"9430_CR112","doi-asserted-by":"crossref","first-page":"233","DOI":"10.4161\/sgtp.2.4.17115","volume":"2","author":"KA Sheikh","year":"2011","unstructured":"Sheikh KA (2011) Autoantobodies activate small GTPase RhoA to modulate neurite outgrowth. Small GTPases 2(4):233\u2013238","journal-title":"Small GTPases"},{"issue":"6497","key":"9430_CR113","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/371474a0","volume":"371","author":"HR Colten","year":"1994","unstructured":"Colten HR (1994) Immunology. Drawing a double-edged sword. Nature 371(6497):474\u2013475","journal-title":"Nature"},{"key":"9430_CR114","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1146\/annurev.immunol.16.1.421","volume":"16","author":"JV Ravetch","year":"1998","unstructured":"Ravetch JV, Clynes RA (1998) Divergent roles for Fc receptors and complement in vivo. Annu Rev Immunol 16:421\u2013432","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"9430_CR115","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.immuni.2005.11.010","volume":"24","author":"F Nimmerjahn","year":"2006","unstructured":"Nimmerjahn F, Ravetch JV (2006) Fcgamma receptors: old friends and new family members. Immunity 24(1):19\u201328","journal-title":"Immunity"},{"issue":"1","key":"9430_CR116","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri2206","volume":"8","author":"F Nimmerjahn","year":"2008","unstructured":"Nimmerjahn F, Ravetch JV (2008) Fcgamma receptors as regulators of immune responses. Nat Rev Immunol 8(1):34\u201347","journal-title":"Nat Rev Immunol"},{"key":"9430_CR117","first-page":"105","volume":"350","author":"F Nimmerjahn","year":"2011","unstructured":"Nimmerjahn F, Ravetch JV (2011) FcgammaRs in health and disease. Curr Top Microbiol Immunol 350:105\u2013125","journal-title":"Curr Top Microbiol Immunol"},{"issue":"11","key":"9430_CR118","doi-asserted-by":"crossref","first-page":"7186","DOI":"10.4049\/jimmunol.172.11.7186","volume":"172","author":"K Su","year":"2004","unstructured":"Su K et al (2004) A promoter haplotype of the immunoreceptor tyrosine-based inhibitory motif-bearing FcgammaRIIb alters receptor expression and associates with autoimmunity. I. Regulatory FCGR2B polymorphisms and their association with systemic lupus erythematosus. J Immunol 172(11):7186\u20137191","journal-title":"J Immunol"},{"issue":"6","key":"9430_CR119","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1084\/jem.20062545","volume":"204","author":"KM Dhodapkar","year":"2007","unstructured":"Dhodapkar KM et al (2007) Selective blockade of the inhibitory Fcgamma receptor (FcgammaRIIB) in human dendritic cells and monocytes induces a type I interferon response program. J Exp Med 204(6):1359\u20131369","journal-title":"J Exp Med"},{"issue":"2","key":"9430_CR120","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nri3582","volume":"14","author":"M Guilliams","year":"2014","unstructured":"Guilliams M et al (2014) The function of Fcgamma receptors in dendritic cells and macrophages. Nat Rev Immunol 14(2):94\u2013108","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"9430_CR121","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1161\/hh0102.102978","volume":"90","author":"M Hernandez","year":"2002","unstructured":"Hernandez M et al (2002) Secretory phospholipase a(2) elicits proinflammatory changes and upregulates the surface expression of fas ligand in monocytic cells: potential relevance for atherogenesis. Circ Res 90(1):38\u201345","journal-title":"Circ Res"},{"issue":"2","key":"9430_CR122","doi-asserted-by":"crossref","first-page":"e88703","DOI":"10.1371\/journal.pone.0088703","volume":"9","author":"G Zhang","year":"2014","unstructured":"Zhang G et al (2014) Fcgamma receptor-mediated inflammation inhibits axon regeneration. PLoS One 9(2):e88703","journal-title":"PLoS One"},{"issue":"Suppl","key":"9430_CR123","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1002\/ana.410270717","volume":"27","author":"JW Griffin","year":"1990","unstructured":"Griffin JW et al (1990) Macrophage responses in inflammatory demyelinating neuropathies. Ann Neurol 27(Suppl):S64\u2013S68","journal-title":"Ann Neurol"},{"issue":"Pt 3","key":"9430_CR124","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/brain\/118.3.577","volume":"118","author":"JW Griffin","year":"1995","unstructured":"Griffin JW et al (1995) Guillain-Barre syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases. Brain 118(Pt 3):577\u2013595","journal-title":"Brain"},{"issue":"4","key":"9430_CR125","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/ana.410330402","volume":"33","author":"GM McKhann","year":"1993","unstructured":"McKhann GM et al (1993) Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol 33(4):333\u2013342","journal-title":"Ann Neurol"},{"issue":"2","key":"9430_CR126","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0301-0082(00)00060-5","volume":"64","author":"R Kiefer","year":"2001","unstructured":"Kiefer R et al (2001) The role of macrophages in immune-mediated damage to the peripheral nervous system. Prog Neurobiol 64(2):109\u2013127","journal-title":"Prog Neurobiol"},{"issue":"3","key":"9430_CR127","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ana.33333","volume":"54","author":"K Susuki","year":"2003","unstructured":"Susuki K et al (2003) Acute motor axonal neuropathy rabbit model: immune attack on nerve root axons. Ann Neurol 54(3):383\u2013388","journal-title":"Ann Neurol"},{"issue":"1","key":"9430_CR128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/gad.1256405","volume":"19","author":"EE Govek","year":"2005","unstructured":"Govek EE, Newey SE, Van Aelst L (2005) The role of the Rho GTPases in neuronal development. Genes Dev 19(1):1\u201349","journal-title":"Genes Dev"},{"issue":"5","key":"9430_CR129","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1523\/JNEUROSCI.4209-05.2006","volume":"26","author":"S Woo","year":"2006","unstructured":"Woo S, Gomez TM (2006) Rac1 and RhoA promote neurite outgrowth through formation and stabilization of growth cone point contacts. J Neurosci 26(5):1418\u20131428","journal-title":"J Neurosci"},{"issue":"Pt 9","key":"9430_CR130","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1093\/brain\/awm004","volume":"130","author":"RA Hughes","year":"2007","unstructured":"Hughes RA et al (2007) Immunotherapy for Guillain-Barre syndrome: a systematic review. Brain 130(Pt 9):2245\u20132257","journal-title":"Brain"},{"key":"9430_CR131","first-page":"CD002063","volume":"9","author":"RA Hughes","year":"2014","unstructured":"Hughes RA, Swan AV, van Doorn PA (2014) Intravenous immunoglobulin for Guillain-Barre syndrome. Cochrane Database Syst Rev 9:CD002063","journal-title":"Cochrane Database Syst Rev"},{"issue":"5787","key":"9430_CR132","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1126\/science.1129594","volume":"313","author":"Y Kaneko","year":"2006","unstructured":"Kaneko Y, Nimmerjahn F, Ravetch JV (2006) Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science 313(5787):670\u2013673","journal-title":"Science"},{"issue":"1","key":"9430_CR133","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1084\/jem.20061788","volume":"204","author":"F Nimmerjahn","year":"2007","unstructured":"Nimmerjahn F, Ravetch JV (2007) The antiinflammatory activity of IgG: the intravenous IgG paradox. J Exp Med 204(1):11\u201315","journal-title":"J Exp Med"},{"issue":"6","key":"9430_CR134","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1212\/WNL.61.6.736","volume":"61","author":"RA Hughes","year":"2003","unstructured":"Hughes RA et al (2003) Practice parameter: immunotherapy for Guillain-Barre syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 61(6):736\u2013740","journal-title":"Neurology"},{"issue":"Pt 3","key":"9430_CR135","first-page":"680","volume":"127","author":"HJ Willison","year":"2004","unstructured":"Willison HJ et al (2004) Synthetic disialylgalactose immunoadsorbents deplete anti-GQ1b antibodies from autoimmune neuropathy sera. Brain 127(Pt 3):680\u2013691","journal-title":"Brain"},{"issue":"1\u20132","key":"9430_CR136","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jneuroim.2008.09.016","volume":"205","author":"V Phongsisay","year":"2008","unstructured":"Phongsisay V et al (2008) Complement inhibitor prevents disruption of sodium channel clusters in a rabbit model of Guillain-Barre syndrome. J Neuroimmunol 205(1\u20132):101\u2013104","journal-title":"J Neuroimmunol"},{"issue":"2","key":"9430_CR137","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.expneurol.2008.10.001","volume":"215","author":"MP Singh","year":"2009","unstructured":"Singh MP et al (2009) Quinpramine is a novel compound effective in ameliorating brain autoimmune disease. Exp Neurol 215(2):397\u2013400","journal-title":"Exp Neurol"},{"issue":"6","key":"9430_CR138","doi-asserted-by":"crossref","first-page":"e21223","DOI":"10.1371\/journal.pone.0021223","volume":"6","author":"G Meyer zu Horste","year":"2011","unstructured":"Meyer zu Horste G et al (2011) Quinpramine ameliorates rat experimental autoimmune neuritis and redistributes MHC class II molecules. PLoS One 6(6):e21223","journal-title":"PLoS One"},{"issue":"1\u20132","key":"9430_CR139","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jns.2011.03.031","volume":"306","author":"AA Pineda","year":"2011","unstructured":"Pineda AA et al (2011) Preventive and therapeutic effects of the selective Rho-kinase inhibitor fasudil on experimental autoimmune neuritis. J Neurol Sci 306(1\u20132):115\u2013120","journal-title":"J Neurol Sci"},{"issue":"Pt 1","key":"9430_CR140","first-page":"18","volume":"128","author":"DA Bechtold","year":"2005","unstructured":"Bechtold DA et al (2005) Axonal protection in experimental autoimmune neuritis by the sodium channel blocking agent flecainide. Brain 128(Pt 1):18\u201328","journal-title":"Brain"},{"issue":"1","key":"9430_CR141","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1517\/14728214.2011.531699","volume":"16","author":"C Walgaard","year":"2011","unstructured":"Walgaard C, Jacobs BC, van Doorn PA (2011) Emerging drugs for Guillain-Barre syndrome. Expert Opin Emerg Drugs 16(1):105\u2013120","journal-title":"Expert Opin Emerg Drugs"},{"issue":"Pt 5","key":"9430_CR142","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/brain\/awm316","volume":"131","author":"SK Halstead","year":"2008","unstructured":"Halstead SK et al (2008) Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model. Brain 131(Pt 5):1197\u20131208","journal-title":"Brain"},{"issue":"10","key":"9430_CR143","doi-asserted-by":"crossref","first-page":"e27067","DOI":"10.1371\/journal.pone.0027067","volume":"6","author":"G Zhang","year":"2011","unstructured":"Zhang G et al (2011) Erythropoietin enhances nerve repair in anti-ganglioside antibody-mediated models of immune neuropathy. PLoS One 6(10):e27067","journal-title":"PLoS One"},{"key":"9430_CR144","first-page":"CD009950","volume":"10","author":"J Liu","year":"2013","unstructured":"Liu J, Wang LN, McNicol ED (2013) Pharmacological treatment for pain in Guillain-Barre syndrome. Cochrane Database Syst Rev 10:CD009950","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"9430_CR145","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.physio.2009.04.001","volume":"95","author":"I Davidson","year":"2009","unstructured":"Davidson I et al (2009) Physiotherapy and Guillain-Barre syndrome: results of a national survey. Physiotherapy 95(3):157\u2013163","journal-title":"Physiotherapy"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9430-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-015-9430-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9430-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T22:42:28Z","timestamp":1559428948000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-015-9430-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,15]]},"references-count":145,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["9430"],"URL":"https:\/\/doi.org\/10.1007\/s12035-015-9430-9","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,15]]}}}